The hallmark of glucose‐6‐phosphate dehydrogenase (G6 PD ) deficiency is red blood cell
( RBC ) destruction in response to oxidative stress. Patients requiring RBC transfusions may …

Background COVID-19, the disease caused by SARS-CoV-2 (severe acute respiratory
syndrome coronavirus 2) can present with symptoms ranging from none to severe. Thrombotic …

The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications for …

The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue
Writing Committee is charged with reviewing, updating and categorizing indications for the …

BACKGROUND A prior practice survey revealed variations in the management of patients
with sickle cell disease (SCD) and stressed the need for comprehensive guidelines. Here we …

Immune-mediated thrombotic thrombocytopenic purpura is characterized by severe
thrombocytopenia and microangiopathic hemolytic anemia. It is primarily caused by immunoglobin G …

Anti‐N‐methyl‐D‐aspartate receptor (NMDA‐R) encephalitis is thought to be one of the
common paraneoplastic‐associated encephalitides. Between February 2001 and February 2011…

Purpose Wilson's disease is a rare autosomal recessive genetic disorder that results in
accumulation of copper in the liver, brain, cornea and kidney. Therapeutic plasma exchange (TPE…

Since 1986, the American Society for Apheresis (ASFA) has published practice guidelines
on the use of therapeutic apheresis in the Journal of Clinical Apheresis (JCA) Special Issue. …

The American Society for Apheresis (ASFA) regularly publishes evidence-based guidelines,
with the most recent edition in 2016, to assist the requesting and/or apheresis physicians …